These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28645134)

  • 1. [Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs)].
    Freudenmann RW; Freudenmann N; Zurowski B; Schönfeldt-Lecuona C; Maier L; Schmieder RE; Lange-Asschenfeldt C; Gahr M
    Dtsch Med Wochenschr; 2017 Aug; 142(16):e100-e107. PubMed ID: 28645134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Different number of contraindications between summaries of product characteristics (SmPC) of drugs with the same active ingredients - an analysis of data from SmPCs of neuropsychiatric drugs].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Fortschr Neurol Psychiatr; 2020 Mar; 88(3):152-169. PubMed ID: 31127605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
    Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sleep disorders and impaired sleep as adverse drug reactions of psychotropic drugs: an evaluation of data of summaries of product characteristics].
    Gahr M; Connemann BJ; Zeiss R; Fröhlich A
    Fortschr Neurol Psychiatr; 2018 Jul; 86(7):410-421. PubMed ID: 29499579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
    Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
    Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units.
    Michalcova J; Vasut K; Airaksinen M; Bielakova K
    BMC Geriatr; 2020 Nov; 20(1):454. PubMed ID: 33158417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications.
    Brouillette J; Nattel S
    Can J Cardiol; 2017 Dec; 33(12):1577-1586. PubMed ID: 29173600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients.
    Tveito M; Correll CU; Bramness JG; Engedal K; Lorentzen B; Refsum H; Høiseth G
    Int Psychogeriatr; 2016 Feb; 28(2):331-40. PubMed ID: 26412479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do induced hypertension and hypotension affect stroke volume variation in man?
    Wajima Z; Shiga T; Imanaga K; Inoue T
    J Clin Anesth; 2012 May; 24(3):207-11. PubMed ID: 22495082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.
    Hayreh SS
    Curr Opin Ophthalmol; 1999 Dec; 10(6):474-82. PubMed ID: 10662254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced hypertension--An unappreciated cause of secondary hypertension.
    Grossman A; Messerli FH; Grossman E
    Eur J Pharmacol; 2015 Sep; 763(Pt A):15-22. PubMed ID: 26096556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive drug test results in patients taking psychotropic drugs. A literature review.
    Masternak S; Padała O; Karakuła-Juchnowicz H
    Psychiatr Pol; 2021 Apr; 55(2):435-446. PubMed ID: 34365490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthostatic hypotension induced by postural change in the rat (tilt test).
    Guillaume P; Hervé S; Picard S; Lacroix P
    Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.45. PubMed ID: 22294225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac side effects of psychiatric drugs.
    Mackin P
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():3-14. PubMed ID: 18098218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Muramoto A; Caldwell J; Albert RK; Lakshminarayan S; Butler J
    Am Rev Respir Dis; 1985 Nov; 132(5):963-6. PubMed ID: 4062050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs.
    Haag S; Junge L; Lotz F; McGauran N; Paulides M; Potthast R; Kaiser T
    J Patient Rep Outcomes; 2021 Dec; 5(1):127. PubMed ID: 34874524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.